Adverum Biotechnologies, Inc. Quarterly Return On Equity in % from Q1 2015 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Adverum Biotechnologies, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2015 to Q2 2024.
  • Adverum Biotechnologies, Inc. Return On Equity for the quarter ending June 30, 2024 was -74.5 %, a 5.32% increase year-over-year.
  • Adverum Biotechnologies, Inc. annual Return On Equity for 2023 was -98.7 %, a 46.3% decline from 2022.
  • Adverum Biotechnologies, Inc. annual Return On Equity for 2022 was -67.4 %, a 68.6% decline from 2021.
  • Adverum Biotechnologies, Inc. annual Return On Equity for 2021 was -40 %, a 26.4% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -74.5 +4.18 +5.32% Apr 1, 2024 Jun 30, 2024
Q1 2024 -90.4 -16.8 -22.8% Jan 1, 2024 Mar 31, 2024
Q4 2023 -98.7 -31.2 -46.3% Oct 1, 2023 Dec 31, 2023
Q3 2023 -88.1 -28.7 -48.2% Jul 1, 2023 Sep 30, 2023
Q2 2023 -78.6 -26.7 -51.4% Apr 1, 2023 Jun 30, 2023
Q1 2023 -73.6 -26.8 -57.2% Jan 1, 2023 Mar 31, 2023
Q4 2022 -67.4 -27.4 -68.6% Oct 1, 2022 Dec 31, 2022
Q3 2022 -59.4 -21.6 -57.2% Jul 1, 2022 Sep 30, 2022
Q2 2022 -51.9 -19.3 -59.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 -46.8 -16 -51.9% Jan 1, 2022 Mar 31, 2022
Q4 2021 -40 -8.34 -26.4% Oct 1, 2021 Dec 31, 2021
Q3 2021 -37.8 -5.57 -17.3% Jul 1, 2021 Sep 30, 2021
Q2 2021 -32.6 +5.01 +13.3% Apr 1, 2021 Jun 30, 2021
Q1 2021 -30.8 +4.7 +13.2% Jan 1, 2021 Mar 31, 2021
Q4 2020 -31.6 +4.95 +13.5% Oct 1, 2020 Dec 31, 2020
Q3 2020 -32.2 +1.26 +3.76% Jul 1, 2020 Sep 30, 2020
Q2 2020 -37.7 -3.89 -11.5% Apr 1, 2020 Jun 30, 2020
Q1 2020 -35.5 -2.16 -6.48% Jan 1, 2020 Mar 31, 2020
Q4 2019 -36.6 -4.17 -12.9% Oct 1, 2019 Dec 31, 2019
Q3 2019 -33.5 -0.84 -2.57% Jul 1, 2019 Sep 30, 2019
Q2 2019 -33.8 -3.15 -10.3% Apr 1, 2019 Jun 30, 2019
Q1 2019 -33.4 -4.85 -17% Jan 1, 2019 Mar 31, 2019
Q4 2018 -32.4 -2.81 -9.49% Oct 1, 2018 Dec 31, 2018
Q3 2018 -32.7 -0.38 -1.18% Jul 1, 2018 Sep 30, 2018
Q2 2018 -30.6 -0.22 -0.72% Apr 1, 2018 Jun 30, 2018
Q1 2018 -28.5 +22.3 +43.9% Jan 1, 2018 Mar 31, 2018
Q4 2017 -29.6 +18.7 +38.8% Oct 1, 2017 Dec 31, 2017
Q3 2017 -32.3 +10.9 +25.2% Jul 1, 2017 Sep 30, 2017
Q2 2017 -30.4 +11.5 +27.5% Apr 1, 2017 Jun 30, 2017
Q1 2017 -50.8 -30.1 -145% Jan 1, 2017 Mar 31, 2017
Q4 2016 -48.4 -30.5 -171% Oct 1, 2016 Dec 31, 2016
Q3 2016 -43.1 -24.9 -137% Jul 1, 2016 Sep 30, 2016
Q2 2016 -41.9 -24.2 -136% Apr 1, 2016 Jun 30, 2016
Q1 2016 -20.8 +2.63 +11.2% Jan 1, 2016 Mar 31, 2016
Q4 2015 -17.8 Oct 1, 2015 Dec 31, 2015
Q3 2015 -18.2 Jul 1, 2015 Sep 30, 2015
Q2 2015 -17.7 Apr 1, 2015 Jun 30, 2015
Q1 2015 -23.4 Jan 1, 2015 Mar 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.